Figure 1 (Vyl00 0004 01)
Vyleesi Injection
Product Images NDC 0713-0897
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 18 technical images submitted to the FDA as part of the official labeling for Vyleesi (NDC 0713-0897). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Cosette Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure 2 (Vyl00 0004 02)
Figure 3 (Vyl00 0004 03)
Figure (Vyl00 0004 04)
This text provides instructions for using Vyleesi, also known as bremelanotide. It contains 1.75 mg of the medication in 0.3 mL and is intended for subcutaneous use only.*
Figure (Vyl00 0004 05)
This appears to be a set of instructions for checking expiration dates and verifying completion of injections using a view window and colored tips. The expiration date should be checked when there is a gray tip showing in half of the view window. When the view window turns purple and the tip is also purple, it indicates that the injection is complete.*
Figure (Vyl00 0004 06)
Figure (Vyl00 0004 07)
Figure (Vyl00 0004 08)
Figure (Vyl00 0004 09)
Figure (Vyl00 0004 10)
Figure (Vyl00 0004 11)
Figure (Vyl00 0004 12)
Figure (Vyl00 0004 13)
Figure (Vyl00 0004 14)
Figure (Vyl00 0004 15)
Dispose of the autoinjector by throwing it away. Proper disposal of medical devices is important for safety and environmental reasons.*
Figure (Vyl00 0004 16)
This is a promotional material for pharmaceuticals marketed by Cosette Pharmaceuticals, Inc. The contact information includes a phone number (1-800-922-1038) and website (www.cosettepharma.com). The document also includes reference numbers such as PCR-750-19314 and 18-0897CP1. It was issued in March 2024.*
Principal Display Panel – 4 Syringe Carton Label (Vyl00 0004 18)
Principal Display Panel – Syringe Label (Vyl00 0004 19)
This is a description for Bremelanotide injection, a medication typically used for subcutaneous administration. The product is available in a single-dose autoinjector containing 175mg/0.3 mL. It is important to administer no more than 1 dose per 24 hours or 8 doses per month. It is advised to store the medication at or below 25°C, avoiding freezing and exposure to light. The specific NDC code for this product is NDC0713-0897-06. Marketed by Coserte Pharmaceuticals Inc., this treatment can provide therapeutic benefits when used as directed.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
